Inflammatory markers in early-stage breast cancer.

被引：0
|
作者：
Petekkaya, Hilbrahim
Aksoy, Sercan
Gecmez, Gizem
Kulahcioglu, Emre
Okoh, Alexis K.
Isler, Deniz Cagin
Demirci, Abdullah Fatih
Sahin, Ugur
Dogan, Erkan
Altundag, Kadri
机构：
[1] Hacettepe Univ Inst Oncol, Ankara, Turkey
[2] Hacettepe Univ Canc Inst, Dept Med Oncol, Ankara, Turkey
[3] Hacettepe Univ Canc, Dept Med Oncol, Ankara, Turkey
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e11537
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Early discontinuation of tamoxifen and aromatase inhibitors (AIs) by postmenopausal women with early-stage breast cancer.
    Charlson, J. A.
    Hedin, T.
    Sparapani, R.
    Guo, C.
    Nattinger, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [32] The potential role of systemic inflammatory markers in predicting recurrence in early-stage cervical cancer
    Bruno, Matteo
    Bizzarri, Nicolo
    Teodorico, Elena
    Certelli, Camilla
    Gallotta, Valerio
    Anchora, Luigi Pedone
    Fagotti, Anna
    Fanfani, Francesco
    Scambia, Giovanni
    Ferrandina, Gabriella
    EJSO, 2024, 50 (01):
  • [33] Evaluating utilization characteristics for the Oncotype DX recurrence score in early-stage breast cancer.
    Chen, C.
    Patt, D. A.
    Kazzaz, D. R.
    Shankleton, J.
    Forsyth, M. T.
    Ganesh, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [34] Adjuvant trastuzumab and vinorelbine (TV) for early-stage HER2+breast cancer.
    McLaughlin, Shannon
    Nakajima, Erika
    Isakoff, Steven J.
    Shin, Jennifer
    Moy, Beverly
    Bardia, Aditya
    Kuter, Irene
    Spring, Laura
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [35] Endocrine therapy non-persistence in young women with early-stage breast cancer.
    Rosenberg, Shoshana M.
    Gelber, Shari I.
    Ruddy, Kathryn Jean
    Tamimi, Rulla
    Wasserman, Johanna
    Schapira, Lidia
    Borges, Virginia F.
    Come, Steven E.
    Meyer, Meghan E.
    Partridge, Ann H.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [36] Gene expression associated with lymphovascular invasion and genomic risk in early-stage breast cancer.
    D'Abreo, Nina
    Rohatgi, Abhinav
    Marks, Douglas Kanter
    Kling, Heather
    Haan, Josien
    Audeh, William
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [37] Cost effectiveness of adjuvant olaparib for BRCA-mutated, early-stage breast cancer.
    Zettler, Christie
    De Silva, Dilanka
    Blinder, Victoria Susana
    Robson, Mark E.
    Elkin, Elena B.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [38] Prevalence of sarcopenia and predictors of body composition among women with early-stage breast cancer.
    Feliciano, Elizabeth
    Caan, Bette Jane
    Prado, Carla
    Kroenke, Candyce
    Alexeeff, Stacey
    Bradshaw, Patrick T.
    Weltzien, Erin
    Castillo, Adrienne
    Chen, Wendy Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (05)
  • [39] High prevalence of vitamin D deficiency in premenopausal women with early-stage breast cancer.
    Hershman, D. L.
    McMahon, D.
    Irani, D.
    Cucchiara, G.
    Crew, K.
    Raptis, G.
    Shane, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 485S - 485S
  • [40] Impact of utilization management policy on uptake of hypofractionated radiation in early-stage breast cancer.
    Chi, Winnie
    Parikh, Ravi Bharat
    Fishman, Ezra
    Zimmerman, Robert Paul
    Gupta, Atul
    Barron, John
    Sylwestrzak, Gosia
    Bekelman, Justin E.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345